Ligand Pharma (LGND) Tops Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $287.59 -1.43%
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q4 EPS of $1.36, $0.49 better than the analyst estimate of $0.87. Revenue for the quarter came in at $50.38 million versus the consensus estimate of $44.09 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- EXL closes $1 billion credit facility, up from $600 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
